Colonial River Investments’s AstraZeneca AZN Stock Holding History

Colonial River Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,847	Closed	-$364K	–	251
2026 Q1	$364K	Sell	1,847 -804	-30%	-$155K	0.13%	157
2025 Q4	$487K	Buy	2,651 +9	+0.3%	+$1.58K	0.17%	128
2025 Q3	$405K	Buy	2,642 +294	+13%	+$44.5K	0.15%	150
2025 Q2	$337K	Buy	2,348 +532	+29%	+$74.6K	0.15%	152
2025 Q1	$267K	Buy	+1,816	New	+$263K	0.15%	153
2023 Q3	–	Sell	-5,724	Closed	-$819K	–	153
2023 Q2	$819K	Buy	+5,724	New	+$842K	0.54%	50

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Colonial River Investments's AZN Position: Q2 2026 in Review

Colonial River Investments sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,847 shares — an estimated $364K sold.

Colonial River Investments first reported a position in AZN in Q2 2023 and held it in 6 quarters. The position peaked at $819K in Q2 2023. 657 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Colonial River Investments reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Colonial River Investments sold 1,847 AstraZeneca shares in Q2 2026, an estimated $364K.
Colonial River Investments first reported a position in AstraZeneca in Q2 2023 and held it in 6 quarters.
Colonial River Investments's AstraZeneca position peaked at $819K in Q2 2023.
657 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.